167 related articles for article (PubMed ID: 20921308)
1. In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.
Gali Y; Delezay O; Brouwers J; Addad N; Augustijns P; Bourlet T; Hamzeh-Cognasse H; Ariën KK; Pozzetto B; Vanham G
Antimicrob Agents Chemother; 2010 Dec; 54(12):5105-14. PubMed ID: 20921308
[TBL] [Abstract][Full Text] [Related]
2. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.
Rohan LC; Moncla BJ; Kunjara Na Ayudhya RP; Cost M; Huang Y; Gai F; Billitto N; Lynam JD; Pryke K; Graebing P; Hopkins N; Rooney JF; Friend D; Dezzutti CS
PLoS One; 2010 Feb; 5(2):e9310. PubMed ID: 20174579
[TBL] [Abstract][Full Text] [Related]
3. Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety.
Mesquita PM; Cheshenko N; Wilson SS; Mhatre M; Guzman E; Fakioglu E; Keller MJ; Herold BC
J Infect Dis; 2009 Aug; 200(4):599-608. PubMed ID: 19586414
[TBL] [Abstract][Full Text] [Related]
4. Reverse transcriptase inhibitors as potential colorectal microbicides.
Herrera C; Cranage M; McGowan I; Anton P; Shattock RJ
Antimicrob Agents Chemother; 2009 May; 53(5):1797-807. PubMed ID: 19258271
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention.
Dezzutti CS; Shetler C; Mahalingam A; Ugaonkar SR; Gwozdz G; Buckheit KW; Buckheit RW
Antiviral Res; 2012 Nov; 96(2):221-5. PubMed ID: 22940075
[TBL] [Abstract][Full Text] [Related]
6. Testing of viscous anti-HIV microbicides using Lactobacillus.
Moncla BJ; Pryke K; Rohan LC; Yang H
J Microbiol Methods; 2012 Feb; 88(2):292-6. PubMed ID: 22226641
[TBL] [Abstract][Full Text] [Related]
7. L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicide.
Zhong M; He B; Yang J; Bao R; Zhang Y; Zhou D; Chen Y; Li L; Han C; Yang Y; Sun Y; Cao Y; Li Y; Shi W; Jiang S; Zhang X; Yan H
Antimicrob Agents Chemother; 2012 Jun; 56(6):3121-32. PubMed ID: 22391529
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 infection of human penile explant tissue and protection by candidate microbicides.
Fischetti L; Barry SM; Hope TJ; Shattock RJ
AIDS; 2009 Jan; 23(3):319-28. PubMed ID: 19114867
[TBL] [Abstract][Full Text] [Related]
9. The nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cells.
Fletcher P; Kiselyeva Y; Wallace G; Romano J; Griffin G; Margolis L; Shattock R
J Virol; 2005 Sep; 79(17):11179-86. PubMed ID: 16103169
[TBL] [Abstract][Full Text] [Related]
10. Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides.
Lackman-Smith C; Osterling C; Luckenbaugh K; Mankowski M; Snyder B; Lewis G; Paull J; Profy A; Ptak RG; Buckheit RW; Watson KM; Cummins JE; Sanders-Beer BE
Antimicrob Agents Chemother; 2008 May; 52(5):1768-81. PubMed ID: 18316528
[TBL] [Abstract][Full Text] [Related]
11. Topical microbicides for prevention of sexually transmitted infections.
Obiero J; Mwethera PG; Wiysonge CS
Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
[TBL] [Abstract][Full Text] [Related]
12. Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model.
Cost M; Dezzutti CS; Clark MR; Friend DR; Akil A; Rohan LC
Antimicrob Agents Chemother; 2012 Jun; 56(6):3058-66. PubMed ID: 22430977
[TBL] [Abstract][Full Text] [Related]
13. Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation.
Dezzutti CS; Russo J; Wang L; Abebe KZ; Li J; Friend DR; McGowan IM; Rohan LC
PLoS One; 2014; 9(7):e102585. PubMed ID: 25025306
[TBL] [Abstract][Full Text] [Related]
14. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.
Moench TR; Mumper RJ; Hoen TE; Sun M; Cone RA
BMC Infect Dis; 2010 Nov; 10():331. PubMed ID: 21087496
[TBL] [Abstract][Full Text] [Related]
15. Effects of tenofovir on cytokines and nucleotidases in HIV-1 target cells and the mucosal tissue environment in the female reproductive tract.
Biswas N; Rodriguez-Garcia M; Shen Z; Crist SG; Bodwell JE; Fahey JV; Wira CR
Antimicrob Agents Chemother; 2014 Nov; 58(11):6444-53. PubMed ID: 25136003
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Commonly Used Excipients on the Epithelial Integrity of Human Cervicovaginal Tissue.
Hu M; Zhou T; Dezzutti CS; Rohan LC
AIDS Res Hum Retroviruses; 2016; 32(10-11):992-1004. PubMed ID: 27611224
[TBL] [Abstract][Full Text] [Related]
17. Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.
Cranage M; Sharpe S; Herrera C; Cope A; Dennis M; Berry N; Ham C; Heeney J; Rezk N; Kashuba A; Anton P; McGowan I; Shattock R
PLoS Med; 2008 Aug; 5(8):e157; discussion e157. PubMed ID: 18684007
[TBL] [Abstract][Full Text] [Related]
18. Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro?
Snead MC; Kourtis AP; Melendez JH; Black CM; Mauck CK; Penman-Aguilar A; Chaney DM; Gallo MF; Jamieson DJ; Macaluso M; Doncel GF
Contraception; 2014 Aug; 90(2):136-41. PubMed ID: 24746557
[TBL] [Abstract][Full Text] [Related]
19. Glycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge.
Haase AT; Rakasz E; Schultz-Darken N; Nephew K; Weisgrau KL; Reilly CS; Li Q; Southern PJ; Rothenberger M; Peterson ML; Schlievert PM
PLoS One; 2015; 10(6):e0129465. PubMed ID: 26057743
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
